Blog

Friulchem Reports on Patent Ruling for Rifaximin

Friulchem Reports on Patent Ruling for Rifaximin

DCAT Value Chain Insights published a new article on Patent Ruling for Rifaximin.

Mexican Institute of Industrial Property (IMPI), the patent and trademark administration body of Mexico, recently dismissed a patent-infringement and unfair competition case filed against Interquim, S.A. de C.V.

Read more

Lascia un commento

Il tuo indirizzo email non sarà pubblicato.